Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting

BACKGROUND: Non-nucleoside reverse transcriptase inhibitor (NNRTI) with stavudine and lamivudine is widely used as the first-line antiretroviral therapy (ART) in resource-limited settings. Lipodystrophy is common and options for switching ART regimen are limited; this situation can lead to patients&...

Descripción completa

Detalles Bibliográficos
Autores principales: Sungkanuparph, Somnuek, Kiertiburanakul, Sasisopin, Apisarnthanarak, Anucha, Malathum, Kumthorn, Watcharananan, Siriorn, Sathapatayavongs, Boonmee
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211500/
https://www.ncbi.nlm.nih.gov/pubmed/18031583
http://dx.doi.org/10.1186/1742-6405-4-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211500/
https://www.ncbi.nlm.nih.gov/pubmed/18031583
http://dx.doi.org/10.1186/1742-6405-4-26

Ejemplares similares